Stockreport

Achillion Reports Preliminary Proof-of-Concept With ACH-4471 for the Treatment of C3G

ACHISON INC A  (ACHN) 
Last achison inc a earnings: 11/7 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.achillion.com/investor-relations
PDF - Greater than 50% improvement in proteinuria (albumin to creatinine ratio) after 14 days of oral dosing with ACH-4471 - - Improvement in complement alternative p [Read more]